HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jeanne-Marie Jacquet Selected Research

Hepatitis B

6/2012Long-term anti-HBs antibody persistence and immune memory in children and adolescents who received routine childhood hepatitis B vaccination.
8/2011Long-term immunogenicity and immune memory after two doses of the adult formulation of a combined hepatitis A and B vaccine in children 1 to 11 years of age.
3/2011Antibody persistence and immune memory 4 years post-vaccination with combined hepatitis A and B vaccine in adults aged over 40 years.
12/2010Five years follow-up following two or three doses of a hepatitis B vaccine in adolescents aged 11-15 years: a randomised controlled study.
10/2010Primary and booster vaccination in Latin American children with a DTPw-HBV/Hib combination: a randomized controlled trial.
10/2010The immunogenicity and safety of a reduced PRP-content DTPw-HBV/Hib vaccine when administered according to the accelerated EPI schedule.
2/2010Immunological persistence in 4-6 and 7-9 year olds previously vaccinated in infancy with hexavalent DTPa-HBV-IPV/Hib.
1/2010Lasting immune memory against hepatitis B in children after primary immunization with 4 doses of DTPa-HBV-IPV/Hib in the first and 2nd year of life.
1/2010Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand.
9/2009Immune memory to hepatitis B virus in 4-9-year old children vaccinated in infancy with four doses of hexavalent DTPa-HBV-IPV/Hib vaccine.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jeanne-Marie Jacquet Research Topics

Disease

20Diphtheria
08/2011 - 01/2005
20Whooping Cough (Pertussis)
08/2011 - 01/2005
19Hepatitis B
06/2012 - 01/2005
19Tetanus
08/2011 - 01/2005
10Poliomyelitis (Polio)
04/2010 - 01/2005
4Hepatitis A (Hepatitis, Infectious)
08/2011 - 06/2010
1Emerging Communicable Diseases (Emerging Infectious Diseases)
12/2021
1Lassa Fever (Fever, Lassa)
12/2021
1Infections
06/2012
1Human Influenza (Influenza)
04/2010
1Pain (Aches)
05/2006

Drug/Important Bio-Agent (IBA)

24VaccinesIBA
12/2021 - 01/2005
13Pentetic Acid (DTPA)FDA LinkGeneric
08/2011 - 01/2005
12AntigensIBA
08/2011 - 01/2005
8AntibodiesIBA
06/2012 - 01/2005
6Conjugate VaccinesIBA
02/2010 - 01/2005
5Combined VaccinesIBA
10/2010 - 10/2007
5diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccineIBA
02/2010 - 09/2008
3Pertussis VaccineIBA
10/2010 - 05/2008
3ToxoidsIBA
09/2010 - 05/2006
3diphtheria-tetanus-acellular pertussis-Hib-hepatitis B vaccineIBA
04/2010 - 08/2006
3Inactivated Poliovirus Vaccine (Salk Vaccine)FDA Link
06/2009 - 10/2006
2pertussis toxoidIBA
08/2011 - 09/2010
2pertactinFDA Link
08/2011 - 09/2010
2Hepatitis A AntibodiesIBA
08/2011 - 06/2010
2Phosphates (Orthophosphate)IBA
10/2010 - 10/2006
2Diphtheria-Tetanus-acellular Pertussis Vaccines (Tripedia)FDA Link
10/2007 - 05/2006
2Tetanus Toxoid (Vaccine, Tetanus)FDA Link
01/2007 - 08/2006
1Surface Antigens (Surface Antigen)IBA
06/2012
1twinrixIBA
03/2011
1RibitolIBA
10/2010
1Hemagglutinins (Hemagglutinin)IBA
09/2010
1Immunoglobulins (Immunoglobulin)IBA
08/2009
1HexavacIBA
01/2009
1Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2009
1Hepatitis B Vaccines (Hepatitis B Vaccine)IBA
10/2006
1pentacelIBA
05/2006